What do the current medical laws sweeping the country mean? How do they work? Contrary to the opinion of many, not just anyone can get medicinal cannabis.
According to these new state laws, you must have at least one illness on a specific list of conditions and this must be diagnosed by a real doctor who recommends cannabis as an appropriate medication.
The doctor provides the patients with a written recommendation that it will alleviate the symptoms of their condition. Patients then have several options open to them depending on which state’s laws they live under.
The first option in many states is to simply take the letter of recommendation from your doctor to a medical marijuana dispensary Same Day Weed Delivery Delta. They will most likely keep a copy of your letter on file and then you can purchase your prescription pot from this dispensary from that point on. If you need to move or buy them from another location, you need only have the doctor’s note with you.
The next option is for you to take the letter from your doctor and send it in with certain health department forms to your state government. Your state’s health department will then send you a medical card. This card can then be used at various dispensaries within your state. This option is required in some states and not in others, but either way you must have a condition for which your doctor can write a letter of recommendation to ingest cannabis.
Most states also provide a third option for patients. You can acquire your doctor’s letter of recommendation and then send it in to the state’s health department with the necessary forms. This third option, however, requires you to request a medical card in order for you to grow your own medicinal cannabis. The laws in this area not only vary by state, but also by county in some cases.
A qualified patient can be in possession of anywhere from eight ounces of them to several pounds and they can grow and maintain from six to fifty plants of varying maturity depending on which county of the state they live in.
Addiction is defined as a chronic, relapsing disease that changes the normal, healthy functioning of the brain apart from causing other harmful consequences. Marijuana or cannabis is the most commonly abused illegal drug in the United States, with most people using it for the first time in their teens.
As marijuana impairs the brain’s ability to form new memories, it can affect the brain system of young adults that is still maturing. A regular use of marijuana by teenagers is associated with an altered reward system, increasing the likelihood that the person will get addicted to other drugs such as heroin, when given an opportunity. Other symptoms of cannabis abuse include rapid heartbeat, disorientation, and lack of physical coordination, often followed by depression or sleepiness.
According to a 2015 report by the National Institute on Drug Abuse (NIDA), illicit drug use in the U.S. has been consistently increasing. In a 2013 survey, conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), an estimated 24.6 million Americans aged 12 or older (9.4 percent of the population) were found to use an illicit drug in a month prior to the survey. In 2013, there were just over 2.8 million new users of illicit drugs, or about 7,800 new users per day.
A 2015 study, led by Dr. Amelia Arria, associate professor of behavioral and community health at the University of Maryland School of Public Health, suggests smoking cannabis in teens is linked with serious brain abnormalities, which can also affect their grades in school. Smoking marijuana by kids leads to lower intelligence and poorer focus, leading to lower grades and dropping out of high school.
Students who smoke marijuana have lower attention span and memory, and thus they may not be functioning at their best in schools and colleges, the study said. The effect of the drug can last for days or weeks, so students tend to skip more lectures and tutorials, with studies taking a backseat. Notably, those who didn’t attend lectures regularly got lower grades and even graduated later than those who attended.
The researchers observed 1,100 students from the University of Maryland for eight years, starting from their first year of university. In the first year, 37 percent students were reportedly found to smoke marijuana at least once in the past 30 days – six days of the month on an average. Unsurprisingly, the students appeared to skip lectures more often with significant rise in marijuana abuse, in turn leading to lower grades and a longer time to graduate. On the contrary, their grades tended to pick up with a reduction in cannabis use.
“When students go to an academic assistance office, rarely does anyone ask them about alcohol or drug use,” said Dr. Arria. “Students often see marijuana as benign. But if you ask them questions like, “How often are you smoking marijuana, drinking, partying?” that alone may help them be more self-reflective and make better choices,” she added.
According to recently conducted experiments, cannabis can be considered an effective remedy for patients diagnosed with multiple sclerosis. While at first the symptomatic improvements experienced by patients with multiple sclerosis who have been administered cannabinoid products were thought to be determined solely by psychological factors, later research has revealed that cannabis actually reduces muscular spasms and stiffness characteristic to multiple sclerosis sufferers. The benefic effects of cannabis on patients with multiple sclerosis have been confirmed by short-term and long-term controlled medical studies.
In 2003, a team of researchers from the Peninsula Medical School in Exeter, UK have made public the results of a series of short-term and long-term studies on the effects of cannabinoids among patients with multiple sclerosis. The previously conducted studies involved the active participation of around 600 patients with advanced-stage multiple sclerosis. The participants were divided in two distinctive groups: the first group received cannabinoid compounds in equal doses, while the second group received placebo medications over a period of 15 weeks. By the end of the experiment, the majority of patients who were administered cannabinoids experienced considerable symptomatic improvements, having less muscular pain and being confronted with milder muscular spasticity (less pronounced muscular spasm). Unlike the group that received cannabinoid compounds over the entire period of the study, the control group (patients who received placebo medications) experienced no improvements in their overall condition.
In order to confirm the relevancy of the findings and to discard any doubts concerning the efficiency of cannabis in ameliorating the symptoms of multiple sclerosis, the study was later repeated. The ulterior study was performed over a period of 12 months, and involved the participation of the same subjects. However, this time the participants were divided into 3 distinctive groups instead of 2 as in the case of the previous experiment. The first group received pills of D9-tetrahydrocannabinol (THC) – the active component in cannabis, the second group received natural cannabis extracts, while the third group received placebo medications.